Cargando…

Oxidative stress parameters of Gaucher disease type I patients

Enzymatic deficiency in Gaucher disease (GD) patients may induce a cascade of events, culminating in secondary effects such as the production of reactive oxygen species (ROS). Detoxification through biological systems which remove or repair the damage may cause the production of peroxides and free r...

Descripción completa

Detalles Bibliográficos
Autores principales: Mello, Alexandre Silva, da Silva Garcia, Cristina, de Souza Machado, Fernanda, da Silva Medeiros, Niara, Wohlenberg, Mariane Farias, Marinho, Jéssica Pereira, Dani, Caroline, Funchal, Cláudia, Coelho, Janice Carneiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4750563/
https://www.ncbi.nlm.nih.gov/pubmed/26937402
http://dx.doi.org/10.1016/j.ymgmr.2015.05.001
_version_ 1782415453293903872
author Mello, Alexandre Silva
da Silva Garcia, Cristina
de Souza Machado, Fernanda
da Silva Medeiros, Niara
Wohlenberg, Mariane Farias
Marinho, Jéssica Pereira
Dani, Caroline
Funchal, Cláudia
Coelho, Janice Carneiro
author_facet Mello, Alexandre Silva
da Silva Garcia, Cristina
de Souza Machado, Fernanda
da Silva Medeiros, Niara
Wohlenberg, Mariane Farias
Marinho, Jéssica Pereira
Dani, Caroline
Funchal, Cláudia
Coelho, Janice Carneiro
author_sort Mello, Alexandre Silva
collection PubMed
description Enzymatic deficiency in Gaucher disease (GD) patients may induce a cascade of events, culminating in secondary effects such as the production of reactive oxygen species (ROS). Detoxification through biological systems which remove or repair the damage may cause the production of peroxides and free radicals that damage all cell components, including proteins, lipids and ADN. The study's aim was the test, using the analysis of plasma samples' the use of lipid peroxidation by thiobarbituric acid reactive substances (TBARS), protein damage by carbonyl assay, non-enzymatic antioxidant defenses by sulfhydryl (SH) content, antioxidant enzymatic defenses by catalase (CAT) and superoxide dismutase (SOD), from patients with GD type I patients who received no prior treatment. Blood samples were collected from 10 patients previously diagnosed with GD type I and from 11 healthy subjects. Chitotriosidase (CT) activity was measured in plasma and the activity of β-glucosidase (GBA) was measured in leukocytes. The results showed a significant increased (p < 0.005) in GD samples when compared to healthy controls in CAT, SOD and SH, but there was no change in TBARS and carbonyl in the comparison between the two groups. In conclusion, the present data indicates the increased levels of enzymatic and non-enzymatic defenses without any effect on lipid peroxidation and damage to proteins. We believe that the results of this study are relevant to understanding the cellular changes involved in this important LSDs.
format Online
Article
Text
id pubmed-4750563
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-47505632016-03-02 Oxidative stress parameters of Gaucher disease type I patients Mello, Alexandre Silva da Silva Garcia, Cristina de Souza Machado, Fernanda da Silva Medeiros, Niara Wohlenberg, Mariane Farias Marinho, Jéssica Pereira Dani, Caroline Funchal, Cláudia Coelho, Janice Carneiro Mol Genet Metab Rep Research Paper Enzymatic deficiency in Gaucher disease (GD) patients may induce a cascade of events, culminating in secondary effects such as the production of reactive oxygen species (ROS). Detoxification through biological systems which remove or repair the damage may cause the production of peroxides and free radicals that damage all cell components, including proteins, lipids and ADN. The study's aim was the test, using the analysis of plasma samples' the use of lipid peroxidation by thiobarbituric acid reactive substances (TBARS), protein damage by carbonyl assay, non-enzymatic antioxidant defenses by sulfhydryl (SH) content, antioxidant enzymatic defenses by catalase (CAT) and superoxide dismutase (SOD), from patients with GD type I patients who received no prior treatment. Blood samples were collected from 10 patients previously diagnosed with GD type I and from 11 healthy subjects. Chitotriosidase (CT) activity was measured in plasma and the activity of β-glucosidase (GBA) was measured in leukocytes. The results showed a significant increased (p < 0.005) in GD samples when compared to healthy controls in CAT, SOD and SH, but there was no change in TBARS and carbonyl in the comparison between the two groups. In conclusion, the present data indicates the increased levels of enzymatic and non-enzymatic defenses without any effect on lipid peroxidation and damage to proteins. We believe that the results of this study are relevant to understanding the cellular changes involved in this important LSDs. Elsevier 2015-05-22 /pmc/articles/PMC4750563/ /pubmed/26937402 http://dx.doi.org/10.1016/j.ymgmr.2015.05.001 Text en © 2015 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Research Paper
Mello, Alexandre Silva
da Silva Garcia, Cristina
de Souza Machado, Fernanda
da Silva Medeiros, Niara
Wohlenberg, Mariane Farias
Marinho, Jéssica Pereira
Dani, Caroline
Funchal, Cláudia
Coelho, Janice Carneiro
Oxidative stress parameters of Gaucher disease type I patients
title Oxidative stress parameters of Gaucher disease type I patients
title_full Oxidative stress parameters of Gaucher disease type I patients
title_fullStr Oxidative stress parameters of Gaucher disease type I patients
title_full_unstemmed Oxidative stress parameters of Gaucher disease type I patients
title_short Oxidative stress parameters of Gaucher disease type I patients
title_sort oxidative stress parameters of gaucher disease type i patients
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4750563/
https://www.ncbi.nlm.nih.gov/pubmed/26937402
http://dx.doi.org/10.1016/j.ymgmr.2015.05.001
work_keys_str_mv AT melloalexandresilva oxidativestressparametersofgaucherdiseasetypeipatients
AT dasilvagarciacristina oxidativestressparametersofgaucherdiseasetypeipatients
AT desouzamachadofernanda oxidativestressparametersofgaucherdiseasetypeipatients
AT dasilvamedeirosniara oxidativestressparametersofgaucherdiseasetypeipatients
AT wohlenbergmarianefarias oxidativestressparametersofgaucherdiseasetypeipatients
AT marinhojessicapereira oxidativestressparametersofgaucherdiseasetypeipatients
AT danicaroline oxidativestressparametersofgaucherdiseasetypeipatients
AT funchalclaudia oxidativestressparametersofgaucherdiseasetypeipatients
AT coelhojanicecarneiro oxidativestressparametersofgaucherdiseasetypeipatients